ArticleInternational journal of cancer2026
Comments on "Prior Immunotherapy Enhances Survival Outcomes of Third-Line Apatinib Treatment in Advanced Gastric Cancer: A Retrospective Cohort Study".
Heng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.